Related Experiment Video
Updated: Feb 13, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
A comprehensive proteomics study on platelet concentrates: Platelet proteome, storage time and Mirasol pathogen
Vishal Salunkhe1, Iris M De Cuyper1, Petros Papadopoulos2
1a Department of Blood Cell Research , Sanquin Research and Landsteiner Laboratory, Academic Medical Centre (AMC), University of Amsterdam (UvA) , Amsterdam , The Netherlands.
Abstract:
Platelet concentrates (PCs) represent a blood transfusion product with a major concern for safety as their storage temperature (20-24°C) allows bacterial growth, and their maximum storage time period (less than a week) precludes complete microbiological testing. Pathogen inactivation technologies (PITs) provide an additional layer of safety to the blood transfusion products from known and unknown pathogens such as bacteria, viruses, and parasites. In this context, PITs, such as Mirasol Pathogen Reduction Technology (PRT), have been developed and are implemented in many countries. However, several studies have shown in vitro that Mirasol PRT induces a certain level of platelet shape change, hyperactivation, basal degranulation, and increased oxidative damage during storage. It has been suggested that Mirasol PRT might accelerate what has been described as the platelet storage lesion (PSL), but supportive molecular signatures have not been obtained. We aimed at dissecting the influence of both variables, that is, Mirasol PRT and storage time, at the proteome level. We present comprehensive proteomics data analysis of Control PCs and PCs treated with Mirasol PRT at storage days 1, 2, 6, and 8. Our workflow was set to perform proteomics analysis using a gel-free and label-free quantification (LFQ) approach. Semi-quantification was based on LFQ signal intensities of identified proteins using MaxQuant/Perseus software platform. Data are available via ProteomeXchange with identifier PXD008119. We identified marginal differences between Mirasol PRT and Control PCs during storage. However, those significant changes at the proteome level were specifically related to the functional aspects previously described to affect platelets upon Mirasol PRT. In addition, the effect of Mirasol PRT on the platelet proteome appeared not to be exclusively due to an accelerated or enhanced PSL. In summary, semi-quantitative proteomics allows to discern between proteome changes due to Mirasol PRT or PSL, and proves to be a methodology suitable to phenotype platelets in an unbiased manner, in various physiological contexts.
Insights
Pathogen inactivation technologies (PITs) like Mirasol PRT may alter platelet function and accelerate storage lesion. Proteomics analysis revealed specific proteome changes related to Mirasol PRT, distinct from the storage lesion, offering unbiased platelet phenotyping.
Area of Science:
- * Transfusion Medicine
- * Proteomics
- * Blood Safety
Background:
- * Platelet concentrates (PCs) are essential but face safety concerns due to bacterial contamination risk during storage.
- * Pathogen inactivation technologies (PITs) enhance blood product safety against various pathogens.
- * Mirasol Pathogen Reduction Technology (PRT) is a PIT, but concerns exist regarding its impact on platelet quality and potential acceleration of platelet storage lesion (PSL).
Purpose of the Study:
- * To investigate the proteomic changes in PCs treated with Mirasol PRT and compare them to control PCs during storage.
- * To determine if Mirasol PRT accelerates or exacerbates the platelet storage lesion (PSL) at a molecular level.
- * To differentiate proteomic alterations caused by Mirasol PRT from those associated with standard PSL.
Main Methods:
- * Comprehensive proteomics analysis using a gel-free, label-free quantification (LFQ) approach.
- * Comparison of Control PCs and Mirasol PRT-treated PCs at multiple storage time points (days 1, 2, 6, and 8).
- * Protein quantification based on LFQ signal intensities analyzed via MaxQuant/Perseus software.
Main Results:
- * Marginal overall differences were observed between Mirasol PRT-treated and control PCs.
- * Significant proteomic changes were identified, specifically linked to known functional alterations induced by Mirasol PRT.
- * The observed proteomic effects of Mirasol PRT were not solely attributable to an accelerated or enhanced PSL.
Conclusions:
- * Semi-quantitative proteomics can effectively distinguish proteome changes induced by Mirasol PRT from those of PSL.
- * Mirasol PRT induces specific proteomic alterations in platelets, independent of PSL.
- * Proteomics is a valuable, unbiased methodology for phenotyping platelets under various conditions, including PIT treatment.
Related Concept Videos
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
The Integrated Rate Law: The Dependence of Concentration on Time
Drug Concentration Versus Time Correlation
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Storage

